NVO · CIK 0000353278
NOVO NORDISK A/S
Annual figures as reported, FY2018–FY2025. Ratios and growth rates derived on-page.
Pharmaceutical Preparations
Company profile
Revenue
DKK 309.1B
▲ +6.4% vs FY2024
Net income
DKK 102.4B
▲ +1.4% vs FY2024
Free cash flow
DKK 59.0B
▼ −20.1% vs FY2024
Diluted EPS
DKK 23.03
▲ +1.8% vs FY2024
Revenue
Annual, as reported
Net income
Annual, as reported
Profitability & returns
quality of earningsMargins
Share of revenue kept at each line
Gross marginOperating marginNet margin
Returns on capital
Net income vs year-end equity and assets
Return on equityReturn on assets
Cash flow
cash generationFree cash flow
Operating cash flow less capital expenditure
Operating cash flow
Net cash from operations
Shareholder returns
capital allocationCapital returned
Cash paid out as dividends and share repurchases
Dividends paidBuybacks
Diluted shares outstanding
Falling count means buybacks outpace dilution
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Net debt
Long-term debt less cash — negative means net cash
Growth rates
compounding, annualizedRevenue CAGR
+20.4%
3y
+19.5%
5y
Net income CAGR
+22.6%
3y
+19.4%
5y
Diluted EPS CAGR
+23.5%
3y
+20.7%
5y
Free cash flow CAGR
−4.0%
3y
+5.0%
5y
Share count change (split-adjusted)
−5.0%
5y
Key ratios
derived per fiscal year| Fiscal year | Gross margin | Op. margin | Net margin | FCF margin | ROE | ROA | Current ratio | Debt / equity | DPS |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | 81.0% | 41.3% | 33.1% | 19.1% | 52.8% | 18.9% | 0.80× | 0.67× | DKK 11.70 |
| FY2024 | 84.7% | 44.2% | 34.8% | 25.4% | 70.4% | 21.7% | 0.74× | 0.72× | DKK 11.40 |
| FY2023 | 84.6% | 44.2% | 36.0% | 35.8% | 78.5% | 26.6% | 0.82× | 0.25× | DKK 9.40 |
| FY2022 | 83.9% | 42.3% | 31.4% | 37.7% | 66.5% | 23.0% | 0.89× | 0.31× | DKK 6.20 |
| FY2021 | 83.2% | 41.7% | 33.9% | 34.6% | 67.5% | 24.6% | 0.86× | 0.38× | DKK 5.20 |
| FY2020 | 83.5% | 42.6% | 33.2% | 36.3% | 66.5% | 29.1% | 0.94× | 0.16× | DKK 4.55 |
| FY2019 | 83.5% | 43.0% | 31.9% | 31.0% | 67.6% | — | — | 0.08× | — |
| FY2018 | — | — | — | — | — | — | — | — | — |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | DKK 309.1B | DKK 250.3B | DKK 127.7B | DKK 102.4B | DKK 23.03 | DKK 119.1B | DKK 60.1B | DKK 542.9B | DKK 348.9B | DKK 194.0B | DKK 26.5B | DKK 131.0B |
| FY2024 | DKK 290.4B | DKK 245.9B | DKK 128.3B | DKK 101.0B | DKK 22.63 | DKK 121.0B | DKK 47.2B | DKK 465.6B | DKK 322.1B | DKK 143.5B | DKK 15.7B | DKK 102.8B |
| FY2023 | DKK 232.3B | DKK 196.5B | DKK 102.6B | DKK 83.7B | DKK 18.62 | DKK 108.9B | DKK 25.8B | DKK 314.5B | DKK 207.9B | DKK 106.6B | DKK 14.4B | DKK 27.0B |
| FY2022 | DKK 177.0B | DKK 148.5B | DKK 74.8B | DKK 55.5B | DKK 12.22 | DKK 78.9B | DKK 12.1B | DKK 241.3B | DKK 157.8B | DKK 83.5B | DKK 12.7B | DKK 25.8B |
| FY2021 | DKK 140.8B | DKK 117.1B | DKK 58.6B | DKK 47.8B | DKK 10.37 | DKK 55.0B | DKK 6.3B | DKK 194.5B | DKK 123.8B | DKK 70.7B | DKK 10.7B | DKK 26.6B |
| FY2020 | DKK 126.9B | DKK 106.0B | DKK 54.1B | DKK 42.1B | DKK 9.01 | DKK 52.0B | DKK 5.8B | DKK 144.9B | DKK 81.6B | DKK 63.3B | DKK 12.2B | DKK 10.4B |
| FY2019 | DKK 122.0B | DKK 101.9B | DKK 52.5B | DKK 39.0B | DKK 8.19 | DKK 46.8B | DKK 8.9B | — | — | DKK 57.6B | DKK 15.4B | DKK 4.5B |
| FY2018 | — | — | — | — | — | — | — | — | — | DKK 51.8B | DKK 15.6B | — |
Latest filings
the most recent regulatory filings6-KForeign issuer report2026-06-29 ↗6-KForeign issuer report2026-06-24 ↗11-KEmployee stock plan report2026-06-22 ↗11-KEmployee stock plan report2026-06-22 ↗SCHEDULE 13G/ASEC filing2026-06-22 ↗6-KForeign issuer report2026-06-15 ↗6-KForeign issuer report2026-06-08 ↗6-KForeign issuer report2026-06-01 ↗6-KForeign issuer report2026-05-27 ↗6-KForeign issuer report2026-05-22 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.